We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Covers Referrals for Risky Pediatric Clinical Trials
Guidance Covers Referrals for Risky Pediatric Clinical Trials
January 10, 2007
The process for IRBs to refer potentially high-risk clinical trials involving children to the FDA for special review is laid out in detail in a new guidance document.